Skip to content

Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course

Press Release

<< Back

Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course


Registration for limited seating open now


WILMINGTON, Del., July 6, 2023 – Ashland is collaborating with The Pii Center for Pharmaceutical Technology, University of Mississippi School of Pharmacy, to present The Advanced Hands-on Course in Tablet Technology at the Ashland state-of-the-art Research Center in Wilmington, Delaware.  

The course convenes Sunday, September 10, 2023, at 6:00 p.m. ET for registration and reception. Morning lectures from Monday through Thursday provide in-depth training in select areas of oral solid dosage form processing and manufacturing, followed by hands-on practice in afternoon laboratory sessions.

Lectures and labs will be conducted by external speakers from Merck & Co., Inc., Bristol Myers Squibb, Freund Vector Corporation, Medelpharm-Korsch AG, Leistritz Advanced Technologies Corporation, and GEA Group, in addition to lecturers from the University of Mississippi and Ashland.

“This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries who work in research and development, manufacturing, quality control assurance, or regulatory compliance,” said Thomas Durig, senior R&D director, life sciences, Ashland. ”The prerequisite is a fundamental understanding of the science of tablet technology and a desire to gain more knowledge and experience in advanced areas of design and practice.

To register and to see the full schedule, please click here.

About Ashland

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social, and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. Approximately 3,900 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries. Visit and to learn more.

Trademark, Ashland, or its subsidiaries, registered in various countries.


Media Relations:

Nancy H. Pitts

+1 (412)628-8791